First Trust Capital Management L.P. Buys New Stake in Drugs Made In America Acquisition Corp. $DMAA

First Trust Capital Management L.P. purchased a new stake in Drugs Made In America Acquisition Corp. (NASDAQ:DMAA – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 786,459 shares of the company’s stock, valued at approximately $8,557,000. First Trust Capital Management L.P. owned 3.24% of Drugs Made In America Acquisition at the end of the most recent reporting period.

Separately, Sona Asset Management US LLC bought a new position in shares of Drugs Made In America Acquisition in the first quarter worth $1,706,000.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of Drugs Made In America Acquisition in a research report on Wednesday, August 26th. One investment analyst has rated the stock with a Sell rating. Based on data from MarketBeat, the company has a consensus rating of “Sell”.

View Our Latest Report on Drugs Made In America Acquisition

Drugs Made In America Acquisition Stock Up 0.0%

Shares of DMAA opened at $10.90 on Monday. Drugs Made In America Acquisition Corp. has a 1-year low of $10.31 and a 1-year high of $10.91. The firm’s 50 day simple moving average is $10.86 and its 200 day simple moving average is $10.65.

Drugs Made In America Acquisition (NASDAQ:DMAA – Get Free Report) last posted its quarterly earnings data on Friday, August 14th. The company reported $0.06 earnings per share for the quarter.

About Drugs Made In America Acquisition

(Free Report)

Drugs Made In America Acquisition Corp. is a special purpose acquisition company formed to pursue a merger, asset acquisition, or similar business combination. It does not operate a pharmaceutical business or manufacture drugs itself. The company’s stated focus was on identifying a business in the pharmaceutical industry, particularly one connected with drug manufacturing in the United States. Its activities were centered on seeking a suitable acquisition or merger candidate.

Featured Articles

Want to see what other hedge funds are holding DMAA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Drugs Made In America Acquisition Corp. (NASDAQ:DMAA – Free Report).

Institutional Ownership by Quarter for Drugs Made In America Acquisition (NASDAQ:DMAA)

Receive News & Ratings for Drugs Made In America Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Drugs Made In America Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.